PACAP and Maxadilan (PAC1 Agonist) Influence Plaque Progression, Migratory Ability, and Mitochondrial Morphology and Dynamics in Vascular Smooth Muscle Cells

Background: Pituitary adenylate cyclase-activating polypeptide (PACAP) functions as an anti-atherogenic neuropeptide. Maxadilan, a PAC1 receptor agonist, offers atheroprotection by acting downstream of vascular inflammation caused by hypercholesterolemia. This study aims to explore how PACAP and Max...

詳細記述

書誌詳細

主要な著者:	Julia Brauschke, Lisa-Marie Schütz, Gabriel A. Bonaterra, Ralf Kinscherf, Anja Schwarz
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2026-06-01
シリーズ:	Cells
主題:	PACAP Maxadilan oxLDL atherosclerosis HCASMC apoptosis
オンライン･アクセス:	https://www.mdpi.com/2073-4409/15/12/1127
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!